The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Adlyxin Starter Kit Discontinuation: What Providers and Prescribers Need to Know in 2026
Adlyxin (lixisenatide) was discontinued in the US in January 2023. Here's what prescribers need to know about transitioning patients and selecting appropriate GLP-1 alternatives.

Allopurinol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical update for providers on allopurinol availability in 2026 — including patient counseling guidance, formulary considerations, and when to switch therapy.

Amethyst 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on Amethyst 28 Day availability issues in 2026 — including therapeutic substitutions, patient counseling, and workflow solutions.

Eplerenone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Eplerenone supply and access challenges in 2026 — including formulary obstacles, cost barriers, and tools to keep patients on guideline-directed therapy.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Etanercept Shortage: What Providers and Prescribers Need to Know in 2026
Etanercept access is increasingly complex for patients in 2026. This provider guide covers the key barriers, prior auth strategies, and how to support continuity of care.

Finasteride Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on finasteride availability in 2026 — supply status, prescribing considerations, alternatives, and tools to help patients find it.

Intuniv Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Intuniv (guanfacine ER) availability in 2026 — pharmacy-level stocking gaps, prescribing implications, safe discontinuation, and patient access tools.

Loteprednol Etabonate: What Providers and Prescribers Need to Know in 2026
A clinical overview of Loteprednol Etabonate supply, formulary status, and prescribing considerations for ophthalmologists and optometrists in 2026.

Rezdiffra (Resmetirom) Access Update: What Providers and Prescribers Need to Know in 2026
A clinical update on Rezdiffra access, patient eligibility, prior authorization strategies, and how to help your MASH patients navigate the specialty pharmacy system in 2026.

Sirolimus Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of sirolimus supply status in 2026 for transplant physicians, nephrologists, and pulmonologists. Includes alternatives, monitoring guidance, and patient support resources.

Spironolactone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on the 2026 spironolactone supply situation: brand discontinuation, patient counseling, alternatives, and therapeutic substitution guidance.

Tresiba Shortage: What Providers and Prescribers Need to Know in 2026
The 2026 Tresiba (insulin degludec) shortage is affecting patients nationwide. Here's a clinical guide for providers on managing continuity of care.